Immunohematology Market Will Be Worth USD 2.3 Billion By 2024: Grand View Research, Inc.
The global immunohematology market is expected to reach a
value of USD 2.3 billion by 2024, according to a new report by Grand View
Research, Inc. This expansion is attributed to the increasing cases of trauma
and rising number of hospital and trauma care centers facilitating emergency
treatments. This creates a need to procure blood to suffice the demand, thus,
boosting the market for immunohematology tests and products.Involvement of
government organizations and NGOs is vast in this field.
Use of technology is contributing to the growth in the
market. Use of mobile applications helps in tracking the blood donation
activity of volunteer donors and also reminds them to donate regularly. In
April 2016, The Indian Red Cross Society launched an application (app) to
facilitate blood banking facility. The app is expected to address the shortage
issue in the region. Moreover, in 2011, the first type of this application was
launched by Hemo bioscience, Inc., a U.S.-based company. The company made the
app available for free for apple users.
Browse full research report on Global Immunohematology Market: http://www.grandviewresearch.com/industry-analysis/immunohematology-market
Further Key Findings From the Study Suggest:
- Immunohematology
reagents dominated the product segment in 2015 due to huge product variety
and an increasing number of blood banks procuring these reagents. The
innovations in the field are resulting in new product launches and also
the efforts are acknowledged at a global level.
- In
December 2013, Sysmex Corporation received the German Design Award for its
XN-2000 hematology reagent. Almost 1,900 products were nominated for the
award.
- Hospitals
dominated the end-use segment in 2015 due to increasing number of
emergency cases because of road accidents and other types of trauma.
Governments and investors are increasingly investing in expanding and
upgrading emergency departments in hospitals to cater to the growing
demand and increase the chances of survival of trauma patients.
- In
2015, North America dominated the market with a revenue share of more than
40%. In the U.S., there is a patient requiring transfusion every 2
seconds. The daily consumption of blood is approximately 36,000 units per
day. This indicates the huge opportunity of growth in this region.
- Some
of the key industry players are Hologic, Inc., Bio-Rad Laboratories, Inc.;
Grifols, ThermoFisher, Immucor; Ortho Clinical Diagnostics; BD (Becton
Dickinson); Siemens Healthcare GmbH; Abbott; and Beckman Coulter, Inc.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/automotive-and-transportation
Grand View Research has segmented the immunohematology
market by product, enduse, and region:
Immunohematology Product Outlook (Market revenue in USD
Million, 2013 - 2024)
- Immunohematology
analyzer
- Immunohematology
reagent
Immunohematology End-Use Outlook (Market revenue in USD
Million, 2013 - 2024)
- Hospitals
- Blood
banks
- Diagnostic
laboratories
Immunohematology Regional Outlook (Market Revenue in USD Million,
2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa
- South
Africa
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-immunohematology-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information:
www.grandviewresearch.com
Comments
Post a Comment